Teva Receives European Commission Approval for ratiopharm Acquisition

05-Aug-2010 - Israel

Teva Pharmaceutical Industries Ltd. announced that the Company received approval from the European Commission to proceed with its acquisition of ratiopharm. In connection with this approval and following the Commission's review of this transaction, Teva made certain limited commitments, which are anticipated to have only a marginal effect on the combined companies' activities. Teva now plans to close the transaction in the near future.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances